Fused ring thrombin receptor antagonists

Details for Australian Patent Application No. 2007238756 (hide)

Owner SCHERING CORPORATION

Inventors Chackalamannil, Samuel; Chelliah, Mariappan V.; Xia, Yan

Agent Griffith Hack

Pub. Number AU-A-2007238756

PCT Pub. Number WO2007/120730

Priority 60/791,748 13.04.06 US

Filing date 11 April 2007

Wipo publication date 25 October 2007

International Classifications

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/443 (2006.01)

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

6 November 2008 PCT application entered the National Phase

  PCT publication WO2007/120730 Priority application(s): WO2007/120730

14 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007238771-Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators

2007238755-Pyridyl amide T-type calcium channel antagonists